Theravance Biopharma saw the highest growth of 1.99% in patent filings and 2.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.32%. GlobalData’s DataBook provides a comprehensive analysis of Theravance Biopharma‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Theravance Biopharma has been focused on protecting inventions in European Patent Office(EPO) with four publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 33% filings and 22% grants. The United States(US), European Patent Office(EPO), Japan(JP), and Finland(FI) patent Office are among the top ten patent offices where Theravance Biopharma is filings its patents. Among the top granted patent authorities, Theravance Biopharma has 22% of its grants in European Patent Office(EPO), 22% in Japan(JP) and 11% in United States(US).
Roche and Johnson & Johnson could be the strongest competitors for Theravance Biopharma
Patents related to rare diseases lead Theravance Biopharma's portfolio
Theravance Biopharma has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Psoriasis related patents lead Theravance Biopharma portfolio followed by lupus erythematosus, and dermatological disorders
Theravance Biopharma has highest number of patents in psoriasis followed by lupus erythematosus, dermatological disorders, vitiligo, and graft versus host disease (gvhd). For psoriasis, nearly 4% of patents were filed and 17% of patents were granted in Q2 2024.
For comprehensive analysis of Theravance Biopharma's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
